Sclerosing encapsulating peritonitis secondary to CAPD: the effect of fibrotic debridement on further dialysis
- PMID: 12018692
Sclerosing encapsulating peritonitis secondary to CAPD: the effect of fibrotic debridement on further dialysis
Abstract
Background: Sclerosing peritonitis (SCP) is a complication of continuous ambulatory peritoneal dialysis (CAPD) and is characterized by progressive fibrosis of the peritoneum. Entrapment of the intestine in a fibrous sac resulting in complete intestinal obstruction is called sclerosing-encapsulating peritonitis (SEP) and represents the most severe form of the disease. Various reports have been pessimistic regarding the surgical outcome when SEP has caused complete intestinal obstruction. Continuation of CAPD after laparotomy is generally considered not feasible. The aim of this article is to present our experience in the surgical management of SEP and, in particular, in the postoperative continuation of CAPD.
Material and methods: Seventeen consecutive patients with SCP among 175 patients undergoing CAPD during a period of 14 years in a single Unit were retrospectively reviewed. Two groups of patients were recognized. The SCP group included 9 patients with incomplete intestinal obstruction that were treated with single peritoneal catheter removal and switching to haemodialysis. The SEP group included 8 patients with complete obstruction that necessitated laparotomy for surgical debridement of the fibrotic tissue and release of the intestinal loops.
Results: Switching to haemodialysis improved the majority of the group of patients. In 2 of the SEP group of patients (early in the series), where enterectomy was inevitable, performance of an intestinal anastomosis resulted in leakage with subsequent fatal outcome. Two of the SEP group of patients were transferred to haemodialysis after the laparotomy. In the remaining 4 SEP patients (50%), exposure of a significant portion of active peritoneal surface was achieved - called "neoperitonization"-and allowed effective continuation of peritoneal dialysis for an average duration of 16 months (range 1-32).
Conclusions: In patients with SEP, careful release of the intestinal loops avoiding enterectomies and even inadvertent intestinal wounds is mandatory. Continuation of peritoneal dialysis after meticulous debridement and removal of the fibrotic tissue is possible and may be effective. To the best of our knowledge, there have not been previously reported cases of continuations of CAPD after laparotomy for SEP.
Similar articles
-
Surgical treatment for sclerosing encapsulating peritonitis.Adv Perit Dial. 2000;16:252-6. Adv Perit Dial. 2000. PMID: 11045305
-
Prognosis for patients with sclerosing encapsulating peritonitis following CAPD.Adv Perit Dial. 1997;13:221-3. Adv Perit Dial. 1997. PMID: 9360686
-
Problems in the surgical management of sclerosing encapsulating peritonitis.Isr J Med Sci. 1993 Nov;29(11):686-8. Isr J Med Sci. 1993. PMID: 8270396 Review.
-
Sclerosing encapsulating peritonitis in a child secondary to peritoneal dialysis.J Pediatr Surg. 2005 May;40(5):e21-3. doi: 10.1016/j.jpedsurg.2005.02.015. J Pediatr Surg. 2005. PMID: 15937801
-
Sclerosing encapsulating peritonitis: early and late results of surgical management in 32 cases. French Associations for Surgical Research.Dig Surg. 1998;15(6):697-702. doi: 10.1159/000018681. Dig Surg. 1998. PMID: 9845640 Review.
Cited by
-
Text mining for case report articles on "peritoneal dialysis" from PubMed database.Ther Apher Dial. 2025 Jun;29(3):459-470. doi: 10.1111/1744-9987.70013. Epub 2025 Mar 26. Ther Apher Dial. 2025. PMID: 40143459 Free PMC article.
-
Sclerosing encapsulating peritonitis in a liver transplant patient: a case report.World J Gastroenterol. 2005 Sep 14;11(34):5412-3. doi: 10.3748/wjg.v11.i34.5412. World J Gastroenterol. 2005. PMID: 16149160 Free PMC article.
MeSH terms
LinkOut - more resources
Medical